Saturday 17 October 2026 Export SPRO’s income statement to Excel — free account

Spero Therapeutics, Inc.

Spero Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $66.8 million, up 39.2% from fiscal 2024. In the quarter to June 2026, revenue fell 95.6%, EPS fell 433.3% and free cash flow grew 69.7%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

1.10 0.03 −2.65%

Follow SPRO

Alert me

Market cap: $65.8M
P/E: 7.9×
Fwd P/E: 4.2×
Dividend yield: —
F-score: 5/9
Altman Z: 1.04
Beneish M: −1.00
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	—	8.67	15.53	0.00	+8 more quarters Free account
P/S ratio Full definition →	—	2.19	1.95	2.61
P/FCF ratio Full definition →	—	18.61	0.00	0.00
P/Operating CF Full definition →	—	8.45	(15.63)	6.07
P/B ratio Full definition →	—	2.53	2.21	3.99
Price to Tangible BV Full definition →	—	2.53	2.21	3.99
EV/Sales Full definition →	—	1.27	1.35	1.41
EV/EBITDA Full definition →	—	5.77	14.30	0.00
EV/Operating CF Full definition →	—	10.76	(7.15)	(2.07)
EV/FCF Full definition →	—	10.82	(7.13)	(2.06)
Quick Ratio Full definition →	6.03	10.23	7.40	3.74
Current Ratio Full definition →	6.12	10.50	7.59	3.83
Net Debt/EBITDA Full definition →	5.12	7.45	(1.28)	6.14
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.00	0.90	0.74	0.43
Operating CF/Net income Full definition →	0.56	(2.20)	(0.26)	(2.36)
Research and Development Expense of Revenue Full definition →	0.00%	1,127.52%	13.54%	157.98%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	1,894.19%	10.41%	76.70%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	0.00%	431.78%	2.44%	19.26%
Graham Net Nets Full definition →	—	0.38	0.44	0.23
Graham Number Full definition →	—	2.37	1.89	0.00
Earnings Yield Full definition →	—	11.54%	6.44%	(42.02%)
Free Cash Flow Yield Full definition →	—	5.37%	(9.70%)	(26.19%)
Revenue per Share Full definition →	0.00	0.00	0.74	0.10
Operating CF per Share Full definition →	(0.09)	0.28	(0.15)	0.31
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.09)	0.28	(0.15)	0.31
Cash per Share Full definition →	0.88	0.98	0.72	0.86
Shareholders Equity per Share Full definition →	0.76	0.92	1.05	0.47
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.76	0.92	1.05	0.47
Free Cash Flow Full definition →	(5.35)	15.86	(8.35)	17.42
Working Capital Full definition →	43.16	52.12	58.42	38.67
Net Current Asset Value Full definition →	43.02	51.53	57.39	24.65
EV/EBIT Full definition →	—	5.77	14.30	0.00
Capex to Sales Full definition →	—	0.00	0.00	0.00
Price to Operating Income Full definition →	—	9.92	20.67	0.00
Other line items
Average Receivables Full definition →	13.47	12.16	38.93	27.87
Average Payables Full definition →	0.47	0.99	4.00	3.74
Average Assets Full definition →	57.44	68.37	89.73	94.67
Average Common Equity Full definition →	38.52	43.37	52.57	46.00

Fold the line items

Columns are period end dates

Stockrow Weekly